Picture of The Chemours logo

CC — The Chemours News Story

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsAdventurousMid CapContrarian

Chemours Co reports results for the quarter ended December 31 - Earnings Summary

* Chemours Co  CC.N  reported quarterly adjusted earnings of
11
cents​​ per share for the quarter ended December 31, lower than
the same quarter last year, when the company reported EPS of 31
cents.  The mean expectation of eleven analysts for the quarter
was for earnings of 12 cents per share. Wall Street expected
results to range from 4 cents to 20 cents per share.
    * Revenue rose 2.4% to $1.39 billion from a year ago;
analysts
expected $1.36 billion. 
    * Chemours Co's reported EPS for the quarter was a loss of 5
cents​.
    * The company reported a quarterly loss of $8 million.
    * Chemours Co shares had fallen by 0.4% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 37.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 6
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the diversified
chemicals peer group is also "hold"

Wall Street's median 12-month price target for Chemours Co is
$25.00 
This summary was machine generated from LSEG data February 18 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      0.12           0.11           Missed
 Sep. 30 2024      0.28           0.40           Beat
 Jun. 30 2024      0.57           0.38           Missed
 Mar. 31 2024      0.18           0.32           Beat

Recent news on The Chemours

See all news